- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Elevated leukocyte count and creatinine predict mortality associated with AKI
A new study published in Journal of International Urology and Nephrology suggests that higher creatinine levels and leukocyte counts were linked to poor outcomes in sepsis ICU patients.
Acute kidney damage (AKI) is one of the most common pathophysiologic illnesses seen in hospitalized patients, and sepsis is commonly linked in its pathophysiology. Reactive oxygen species (ROS) appear to have a substantial role in sepsis-induced AKI. Proposed processes include cell membrane lipid peroxidation, protein denaturation, and direct DNA damage, all of which are harmful. These alterations are indicative of renal oxidative damage. As a result, Alaa Efat and colleagues undertook this study to assess the antioxidant effects of indirect bilirubin and uric acid on the outcomes of sepsis-related AKI.
For this study serum levels of uric acid, bilirubin (mainly indirect), and procalcitonin were measured in 98 patients hospitalized to the critical care unit of a large tertiary care institution with sepsis and AKI. The key outcomes investigated were the requirement for hemodialysis and mortality.
The key findings of this study were as follow:
1. Thirty-two (33%) individuals had AKI and required hemodialysis (HD).
2. When compared to those who did not require HD, these patients had higher SOFA ratings (p 0.001) and lower levels of indirect bilirubin (p 0.001).
3. Serum uric acid levels did not differ statistically significantly.
4. Creatinine level, leukocyte count, and total & indirect bilirubin levels were found to be significant predictors of patient mortality in a logistic regression study.
In conclusion, raised roundabout bilirubin levels appear to make a possibly defensive difference, however given the restricting impact of complete bilirubin levels and that of higher backhanded bilirubin levels, more exploration is expected to recognize the likely antioxidative impacts of circuitous bilirubin in sepsis, especially in accordance with kidney injury, as well as potential future treatments focusing on the pathways it impacts.
Reference:
Efat, A., Shoeib, S., Ebrahim, E., Kassemy, Z., Bedair, H. M., & Abozenah, M. (2022). Impact of indirect bilirubin and uric acid on outcomes of sepsis-associated acute kidney injury (sAKI). In International Urology and Nephrology. Springer Science and Business Media LLC. https://doi.org/10.1007/s11255-022-03232-2
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751